172 related articles for article (PubMed ID: 22766444)
1. Application of organogels as oral controlled release formulations of hydrophilic drugs.
Iwanaga K; Kawai M; Miyazaki M; Kakemi M
Int J Pharm; 2012 Oct; 436(1-2):869-72. PubMed ID: 22766444
[TBL] [Abstract][Full Text] [Related]
2. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
5. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents.
Esposito CL; Tardif V; Sarrazin M; Kirilov P; Roullin VG
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():110999. PubMed ID: 32993979
[TBL] [Abstract][Full Text] [Related]
7. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation.
Verhoeven E; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2006 Jul; 63(3):320-30. PubMed ID: 16517135
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembling Organogels Based on Pluronic and Lecithin for Sustained Release of Etodolac: In Vitro and In Vivo Correlation.
Mohammed AM; Faisal W; Saleh KI; Osman SK
Curr Drug Deliv; 2017; 14(7):926-934. PubMed ID: 27593184
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
Lamprecht A; Saumet JL; Roux J; Benoit JP
Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
[TBL] [Abstract][Full Text] [Related]
11. Formulations based on alpha cyclodextrin and soybean oil: an approach to modulate the oral release of lipophilic drugs.
Hamoudi MC; Bourasset F; Domergue-Dupont V; Gueutin C; Nicolas V; Fattal E; Bochot A
J Control Release; 2012 Aug; 161(3):861-7. PubMed ID: 22634090
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
[TBL] [Abstract][Full Text] [Related]
13. Organogels based on amino acid derivatives and their optimization for drug release using response surface methodology.
Hu B; Yan H; Sun Y; Chen X; Sun Y; Li S; Jing Y; Li H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):266-275. PubMed ID: 31851842
[TBL] [Abstract][Full Text] [Related]
14. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers.
Yu DG; Shen XX; Branford-White C; White K; Zhu LM; Bligh SW
Nanotechnology; 2009 Feb; 20(5):055104. PubMed ID: 19417335
[TBL] [Abstract][Full Text] [Related]
15. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
16. Potential of amorphous microporous silica for ibuprofen controlled release.
Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
[TBL] [Abstract][Full Text] [Related]
17. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
Chansanroj K; Betz G
Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
[TBL] [Abstract][Full Text] [Related]
18. Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form.
Tang YD; Venkatraman SS; Boey FY; Wang LW
Int J Pharm; 2007 May; 336(1):159-65. PubMed ID: 17194555
[TBL] [Abstract][Full Text] [Related]
19. Theophylline controlled-release formulations: in vivo-in vitro correlations.
Yu Z; Schwartz JB; Sugita ET
Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules.
Walter K; Weiss G; Laicher A; Stanislaus F
Arzneimittelforschung; 1995 Aug; 45(8):886-90. PubMed ID: 7575754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]